These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21454487)

  • 1. Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.
    Guo N; Woeller CF; Feldon SE; Phipps RP
    J Biol Chem; 2011 May; 286(21):18856-67. PubMed ID: 21454487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor γ agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCβ2.
    Zhuang Y; Yin Q
    Cell Biochem Biophys; 2013 Nov; 67(2):583-90. PubMed ID: 23479332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
    Galgoczi E; Molnar Z; Katko M; Ujhelyi B; Steiber Z; Nagy EV
    Chem Biol Interact; 2024 Jun; 396():111045. PubMed ID: 38729283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.
    Guo N; Baglole CJ; O'Loughlin CW; Feldon SE; Phipps RP
    J Biol Chem; 2010 May; 285(21):15794-804. PubMed ID: 20308056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.
    Ferguson HE; Kulkarni A; Lehmann GM; Garcia-Bates TM; Thatcher TH; Huxlin KR; Phipps RP; Sime PJ
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):722-30. PubMed ID: 19286977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
    Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R
    Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.
    Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV
    J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid transient increase in hyaluronan synthase-2 mRNA initiates secretion of hyaluronan by corneal keratocytes in response to transforming growth factor beta.
    Guo N; Kanter D; Funderburgh ML; Mann MM; Du Y; Funderburgh JL
    J Biol Chem; 2007 Apr; 282(17):12475-83. PubMed ID: 17327235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
    Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
    Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Hyaluronan (HA) Metabolism Mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA Synthases in Growth Factor-stimulated Fibroblasts.
    Nagaoka A; Yoshida H; Nakamura S; Morikawa T; Kawabata K; Kobayashi M; Sakai S; Takahashi Y; Okada Y; Inoue S
    J Biol Chem; 2015 Dec; 290(52):30910-23. PubMed ID: 26518873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
    Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M
    Respiration; 2009; 77(3):311-9. PubMed ID: 18974632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta induced hyaluronan synthesis in orbital fibroblasts involves protein kinase C betaII activation in vitro.
    Wang HS; Tung WH; Tang KT; Wong YK; Huang GJ; Wu JC; Guo YJ; Chen CC
    J Cell Biochem; 2005 May; 95(2):256-67. PubMed ID: 15770661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
    Wu M; Melichian DS; Chang E; Warner-Blankenship M; Ghosh AK; Varga J
    Am J Pathol; 2009 Feb; 174(2):519-33. PubMed ID: 19147827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib and Pioglitazone as Potential Therapeutics for Regulating TGF-β-Induced Hyaluronan in Dysthyroid Myopathy.
    Cheng AM; Yin HY; Chen A; Liu YW; Chuang MC; He H; Tighe S; Sheha H; Liao SL
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1951-9. PubMed ID: 27092721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.